Sun Pharmaceutical Industries (SUNPHARMA) Share Price Rises 2.17% as Market Cap Stands at Rs 4,48,687.64 Cr
- November 19, 2026
- Posted by: Kunal Singla
- Category: News
Sun Pharmaceutical Industries Share Price is rising today, with SUNPHARMA trading at Rs 1,912.95, up 2.17% from the previous close of Rs 1,872.3. The company’s market capitalisation stands at Rs 4,48,687.64 Cr, keeping the Sun Pharmaceutical Industries Share Price in the spotlight among healthcare names. Univest data confirms the move itself, though no company-specific trigger has been identified. The Sun Pharmaceutical Industries Share Price today matters because the move is visible on a stock with a large market value, a premium valuation and strong profitability ratios compared with several industry peers. Investors tracking Sun Pharmaceutical Industries Stock News can use the day’s price action, fundamental ratios and sector benchmark to understand the context without reading a narrative into the move.
For readers looking up Sun Pharmaceutical Industries Share Price Today, the key point is simple: the stock is trading higher in early hours, and the move is measurable in price terms only. The latest Univest figures show a narrow intraday range so far, with the share price remaining close to the day’s high. That keeps the Sun Pharmaceutical Industries Share Price live and relevant for market watchers assessing price action, valuation and sector positioning.
Sun Pharmaceutical Industries Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,912.95 |
| Previous Close | Rs 1,872.3 |
| Today's Move | Rs 40.65 (+2.17%) |
| Open | Rs 1,872.3 |
| High | Rs 1,913.9 |
| Low | Rs 1,872.2 |
| Market Capitalisation | Rs 4,48,687.64 crore |
| Market Cap Category | Large Cap |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) rose to Rs 1,912.95 from the previous close of Rs 1,872.3, a move of Rs 40.65 or 2.17%. The stock opened at Rs 1,872.3, reached a high of Rs 1,913.9, recorded a low of Rs 1,872.2.
Sun Pharmaceutical Industries Share Price is up 2.17% today, moving Rs 40.65 higher from the previous close and trading at Rs 1,912.95. The Sun Pharmaceutical Industries Share Price opened at Rs 1,872.3, touched a high of Rs 1,913.9 and a low of Rs 1,872.2, which places the stock near the top of its day’s range as of 19 November 2026 at 1:22:53 PM IST.
The price action matters because the Sun Pharmaceutical Industries Share Price has moved above the previous close without any verified company-specific event being established. That makes the Sun Pharmaceutical Industries Share Price update a clean price-led move rather than a story-led one. For investors scanning Sun Pharmaceutical Industries Share News or SUNPHARMA Share Price Live updates, the focus remains on the exact change in trading levels and the day’s high-low band. The Sun Pharmaceutical Industries Share Price continues to be a stock-market headline today, and the next section places that movement into fundamental context.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,48,687.64 crore |
| P/E Ratio | 40.96x |
| P/B Ratio | 5.03x |
| ROE | 14.85% |
| ROCE | 19.11% |
| EPS | Rs 45.71 |
| Book Value Per Share | Rs 372.1 |
| Dividend Yield | 0.85% |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) fundamental metrics show P/E 40.96x, P/B 5.03x, ROE 14.85%, ROCE 19.11%. Read together, these ratios describe the company’s position rather than a recommendation.
Sun Pharmaceutical Industries Ltd. has a market capitalisation of Rs 4,48,687.64 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 40.96x, P/B at 5.03x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.85% and ROCE of 19.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 45.71, book value per share of Rs 372.1, dividend yield of 0.85%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.6x, median ROE of 11.23%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 40.96x |
| Benchmark Median P/E | 30.6x |
| Benchmark Average P/E | 59.27x |
| Benchmark P/E Range | 2.71x to 1,378.1x |
| Company P/B Ratio | 5.03x |
| Benchmark Median P/B | 2.8x |
| Company ROE | 14.85% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 19.11% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 4,48,687.64 crore |
| Benchmark Median Market Cap | Rs 789.58 crore |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 40.96x, which is above the benchmark median of 30.6x, a difference of +33.86%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROE of 14.85%, which is above the benchmark median of 11.23%, a difference of +32.24%. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a ROCE of 19.11%, which is above the benchmark median of 13.1%, a difference of +45.88%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Divi's Laboratories Ltd. | DIVISLAB | 2,95,080.27 | 87.38 | 16.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,77,677.43 | 83.06 | 9.6 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,26,433.06 | 93.64 | 20.7 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,969.79 | 28.52 | 4.29 | 19.69 | 21.39 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,15,852.16 | 41.65 | 3 | 11.69 | 13.75 |
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a P/E ratio of 40.96x compared with the displayed peer median of 83.06x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 14.85% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.11% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sun Pharmaceutical Industries Ltd. (SUNPHARMA) has a market capitalisation of Rs 4,48,687.64 crore. It is larger by market capitalisation than all 5 peers shown.
Why Investors Are Watching Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Share Price is up 2.17% today, with the stock trading at Rs 1,912.95 and holding near the day’s high.
- The Sun Pharmaceutical Industries Share Price is backed by a market cap of Rs 4,48,687.64 Cr, which keeps it relevant in healthcare market updates.
- Fundamental Analysis shows P/E of 40.96, P/B of 5.03, ROE of 14.85%, ROCE of 19.11%, EPS of 45.71 and book value of 372.1.
- Sector analysis places the Sun Pharmaceutical Industries Share Price above the industry median on P/E and profitability ratios.
- Peer comparison shows the stock with the largest market capitalisation in the named group and a mix of premium valuation and solid return ratios.
About Sun Pharmaceutical Industries
Sun Pharmaceutical Industries Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is widely followed in the Indian Stock Market because it is a large listed pharma business with scale across medicines and related healthcare products. Sun Pharmaceutical Industries Stock News is often read alongside its financial ratios, especially when the Sun Pharmaceutical Industries Share Price moves sharply in a single trading day.
As a pharmaceutical company, Sun Pharmaceutical Industries earns from drug and healthcare product operations across its business mix. Its market position is reflected in the large market cap, the premium P/E and P/B ratios, and the profitability profile captured through ROE and ROCE. For anyone following Sun Pharmaceutical Industries Share Price Today, the business backdrop matters because it helps frame the valuation and the stock’s place within the healthcare universe. The Sun Pharmaceutical Industries Share Price is therefore not just a price point; it is also a reflection of a large, established healthcare franchise with measurable earnings and capital efficiency metrics.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Sun Pharmaceutical Industries Share Price rising today?
Ans. Sun Pharmaceutical Industries Share Price is higher by 2.17% today, but no company-specific catalyst is established. The stock is trading at Rs 1,912.95 versus the previous close of Rs 1,872.3.
What is the current Sun Pharmaceutical Industries Share Price?
Ans. Sun Pharmaceutical Industries Share Price is trading at Rs 1,912.95. The move is Rs 40.65 above the previous close, and the stock remains a key healthcare name in today’s market update.
How much has Sun Pharmaceutical Industries Share Price moved today?
Ans. Sun Pharmaceutical Industries Share Price is up 2.17% today. The price range so far spans Rs 1,872.2 to Rs 1,913.9, showing the stock near the upper end of its day’s band.
What is Sun Pharmaceutical Industries market cap?
Ans. Sun Pharmaceutical Industries has a market capitalisation of Rs 4,48,687.64 Cr. That scale is far above the industry median in the same sector benchmark and is a major part of the stock’s profile.
Is Sun Pharmaceutical Industries Share Price expensive based on valuation?
Ans. The Sun Pharmaceutical Industries Share Price carries a P/E of 40.96 and a P/B of 5.03. Both are above the industry median in the benchmark, so the valuation sits at a premium to the centre of the group.
How does Sun Pharmaceutical Industries compare with peers?
Ans. Sun Pharmaceutical Industries has the largest market capitalisation in the peer set listed here. Its P/E is below some high-multiple peers, while ROE and ROCE remain solid against several healthcare names.
What do ROE and ROCE show for Sun Pharmaceutical Industries Share Price?
Ans. Sun Pharmaceutical Industries reports ROE of 14.85% and ROCE of 19.11%. These figures are above the industry median in the benchmark and help explain the financial context behind the stock’s valuation.
What are the EPS, book value and dividend yield for Sun Pharmaceutical Industries?
Ans. EPS is 45.71, book value per share is 372.1 and dividend yield is 0.85%. These three numbers help frame earnings, accounting net worth and historical payout relative to the Sun Pharmaceutical Industries Share Price.
Track Sun Pharmaceutical Industries Share Price on Univest
Use Sun Pharmaceutical Industries Ltd. (SUNPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Sun Pharmaceutical Industries Share Price on Univest for live share price updates, fundamental ratios, 52-week levels and market insights. The platform also helps users review Sun Pharmaceutical Industries Share Price Today in context, alongside sector benchmarks, peer comparison and stock performance snapshots.
For Sun Pharmaceutical Industries Stock News followers, Univest keeps the focus on verified price action and financial context. That makes it easier to monitor Sun Pharmaceutical Industries Share Price Rise updates, compare valuation with the Healthcare sector and revisit the company’s market cap, P/E, P/B, ROE, ROCE, EPS, book value and dividend yield in one place.